FOI 596/19/20
DDVA HREC/OUT/2020/BN16087438
MINUTES OF THE 27th MEETING OF THE DEPARTMENTS OF DEFENCE
AND VETERANS’ AFFAIRS HUMAN RESEARCH ETHICS COMMITTEE
(DDVAHREC) EC00460
AT 1300 HOURS ON MONDAY 11 MAY 2020
Attendees:
Mr Ian Tindall
Chair (via videoconference)
Mr Tony Cotton
Deputy Chair
Mr Lindsay Roe
Layperson
Ms Margaret Proctor
Layperson (via teleconference)
Mr Stephen Brimstone
Professional care/counselling (via teleconference)
Rev Dr Nikki Coleman
Pastoral care
Dr Wendy Bonython
Lawyer (via teleconference)
Dr Bert Biggs
Researcher (via teleconference)
Dr Jane Harte
Researcher (via teleconference)
Secretariat:
Ms Terri Davis
Assistant Director Research Ethics
Ms Megan Barker
Senior Research Ethics Officer
Ms Lindsay Pennock
Outgoing Assistant Director Research Ethics
Ms Kate Swain
Research Administration Officer (via teleconference)
Apologies with comments:
Dr Chris Wilson
Contemporary Veteran (out-of-session)
Apologies:
Dr Vicki Ross
Defence Health Graduate
ITEM 1 – OPENING
1.01 – Opening
1.
The Chair opened the meeting at 1300 hours, welcomed members and noted
apologies from those listed above.
2.
The Chair noted that Dr Wilson (contemporary veteran) has provided out-of-
session feedback on the tabled agenda items.
1.02 – Introduction of Observers
3.
s47F
and s47F
were present for the initial part of the meeting
however, they excused themselves once all members were present (prior to the
commencement of agenda item 2).
Page 1 of 45
FOI 596/19/20
1.03 – Update on application 241-20 Chloroquine Chemoprophylaxis
Countermeasure against COVID19 (C4)
4.
The Committee noted that:
a.
the research proposal was considered out-of-session by the full HREC
b.
some members requested changes and/or points of clarification on the
proposal and five members were in dissent with the general consensus of the
committee
c.
CDRE Curtis declared a conflict of interest and abstained from the
consideration of this application
d.
the existence of 241-20
Chloroquine Chemoprophylaxis Countermeasure
against COVID19 (C4) in March 2020 was not mentioned at the previous
meeting, nor in the Minutes, notwithstanding it has already been granted
ethical approval out-of-session by the Chair.
e.
an adverse event report has been submitted. Further information will be
provided as part of the agenda at the June 2020 DDVA HREC meeting
f.
a protocol amendment is anticipated in the near future
g.
process issues regarding the consideration of this application will be
discussed as part of the planned larger review.
s22
Page 2 of 45
FOI 596/19/20
s22
Page 3 of 45
FOI 596/19/20
s22
Page 4 of 45
FOI 596/19/20
s22
Page 5 of 45
FOI 596/19/20
s22
Page 6 of 45
FOI 596/19/20
s22
Page 7 of 45
FOI 596/19/20
s22
Page 8 of 45
FOI 596/19/20
s22
Page 9 of 45
FOI 596/19/20
s22
Page 10 of 45
FOI 596/19/20
s22
Page 11 of 45
FOI 596/19/20
s22
Page 12 of 45
FOI 596/19/20
s22
Page 13 of 45
FOI 596/19/20
s22
Page 14 of 45
FOI 596/19/20
s22
Page 15 of 45
FOI 596/19/20
s22
Page 16 of 45
FOI 596/19/20
s22
Page 17 of 45
FOI 596/19/20
s22
Page 18 of 45
FOI 596/19/20
s22
Page 19 of 45
FOI 596/19/20
s22
Page 20 of 45
FOI 596/19/20
s22
Page 21 of 45
FOI 596/19/20
s22
Page 22 of 45
FOI 596/19/20
s22
Page 23 of 45
FOI 596/19/20
s22
Page 24 of 45
FOI 596/19/20
s22
Page 25 of 45
FOI 596/19/20
s22
Page 26 of 45
FOI 596/19/20
s22
Page 27 of 45
FOI 596/19/20
s22
Page 28 of 45
FOI 596/19/20
ITEM 10 – NEXT MEETING
74.
The next DDVA HREC meeting is scheduled for 22 June 2020 at 1300 hours,
at Campbell Park Offices in Canberra. The Assistant Director Research Ethics is in
the process of finalising the agenda for the remainder of the year and aims to have this
done by COB 18 May 2020.
Action: ADRE to finalise meeting roster for the remainder of the year and
circulate it to members.
75.
The meeting closed at 1725 hours.
s22
s22
Mr Ian Tindall
Ms Terri Davis
Chair
Meeting Secretary
16 May 2020
16 May 2020
Distribution list:
DDVA HREC
For information:
Director General Health Business & Plans (Defence)
Chief Data Officer (DVA)
Director Strategic Clinical Assurance and Ethics (Defence)
Director Data Information and Insights (DVA)
.
Page 29 of 45
FOI 596/19/20
s22
241-20 – Chloroquine
Major Scott Hahn
22 March 2020 - application received. 25 March 2020 - Approval provided by DDVA HREC
Chemoprophylaxis
Australian Defence
Chair and sub-committee.
Countermeasure Against
Force Malaria and
Ethical approval granted from 25 March 2020 – 25 March 2022.
COVID-19 (C4) Study
Infectious Disease
Research project is confidential in nature. Approval provided out of session due to time criticality
(Greater than low risk)
Institute (ADFMIDI)
of the COVID-19 crisis.
9 April 2020 - The National Health and Medical Research Council (NHMRC) provided an external
review and made suggestions for improvement. These suggestions were implemented and the 2nd
sub-committee was formed to encompass the full committee categories with the subcommittees
review.
10/11 April 2020 - 2nd Sub-committee review.
11 April 2020 - Reconsideration and approval to proceed with minor consideration by Acting
DDVA HREC Chair and sub-committee.
17 April 20202 - DDVA HREC Committee (all members) reviewed, provided comment and
provided recommendation.
Page 30 of 45
FOI 596/19/20
Protocol number and title
Principal
Notes
Investigator and
Institution
The majority of the committee Approved/Approved with changes and the approval was provided to
the Researchers (see 1.03 for more information).
s22
Page 31 of 45
FOI 596/19/20
s22
Page 32 of 45
FOI 596/19/20
s22
Page 33 of 45
FOI 596/19/20
s22
Page 34 of 45
FOI 596/19/20
s22
Page 35 of 45
FOI 596/19/20
s22
Page 36 of 45
FOI 596/19/20
s22
Page 37 of 45
FOI 596/19/20
s22
Page 38 of 45
FOI 596/19/20
s22
Page 39 of 45
FOI 596/19/20
s22
Page 40 of 45
FOI 596/19/20
s22
Page 41 of 45
FOI 596/19/20
s22
Page 42 of 45
FOI 596/19/20
s22
Page 43 of 45
FOI 596/19/20
s22
s
2
Page 44 of 45
2
FOI 596/19/20
s22
Page 45 of 45
